Proteome Sciences plc (PMSNF)
| Market Cap | 11.16M |
| Revenue (ttm) | 6.12M |
| Net Income (ttm) | -4.26M |
| Shares Out | n/a |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,500 |
| Average Volume | 16,635 |
| Open | 0.0270 |
| Previous Close | 0.0280 |
| Day's Range | 0.0270 - 0.0270 |
| 52-Week Range | 0.0200 - 0.0800 |
| Beta | 0.17 |
| RSI | 46.60 |
| Earnings Date | Mar 31, 2025 |
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathw... [Read more]
Financial Performance
In 2024, Proteome Sciences's revenue was 4.89 million, a decrease of -2.80% compared to the previous year's 5.03 million. Losses were -3.41 million, 39.4% more than in 2023.
Financial numbers in GBP Financial StatementsNews
AIM Market Roundup: Proteome Sciences, UKRProduct, Staffline
Proteome Sciences, UKRProduct, Staffline, ZOO Digital, Active Energy are today's biggest risers and fallers on London's AIM market